1.D'Agata EM, Mount DB, Thayer V, Schaffner W. Hospital-acquired infections among chronic hemodialysis patients. Am J Kidney Dis 2000; 35:1083–1088.
2.Horl WH. Neutrophil function and infections in uremia. Am J Kidney Dis 1999;33:xlv–xlvii.
3.Sexton DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am 2001;15:731–742, vii.
4.Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation. National Kidney Foundation report on dialyzer reuse. Am J Kidney Dis 1997;30:859–871.
5.Centers for Disease Control and Prevention. Outbreaks of gram-negative bacterial bloodstream infections traced to probable contamination of hemodialysis machines—Canada, 1995; United States, 1997; and Israel, 1997. MMWR 1998;47:55–58.
6.Alter MJ, Favero MS, Miller JK, Coleman PJ, Bland LA. Reuse of hemodialyzers: results of nationwide surveillance for adverse effects. JAMA 1988;260:2073–2076.
7.Longfield RN, Wortham WG, Fletcher LL, Nauscheutz WF. Clustered bacteremias in a hemodialysis unit: cross-contamination of blood tubing from ultrafiltrate waste. Infect Control Hosp Epidemiol 1992;13:160–164.
8.Grohskopf LA, Roth VR, Feikin DR, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001;344:1491–1497.
9.Alfurayh O, Sabeel A, Al Ahdal MN, et al. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol 2000;20:103–106.
10.Garg PP, Frick KD, Diener-West M, Powe NR. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med 1999;341:1653–1660.
11.Arnow PM, Garcia-Houchins S, Neagle MB, Bova JL, Dillon JJ, Chou T. An outbreak of bloodstream infections arising from hemodialysis equipment. J Infect Dis 1998;178:783–791.
12.Tokars JI, Miller ER, Alter MJ, Arduino MJ. National Surveillance of Dialysis Associated Diseases in the United States, 1999. Atlanta, GA: Centers for Disease Control and Prevention; 1999.
13.Peterson LR, Brossette SE. Hunting healthcare-associated infections from the clinical microbiology laboratory: passive, active, and virtual surveillance. J Clin Microbiol 2002;40:1–4.
14.Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 1986;315:91–96.
15.Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996;156:1458–1462.
16.Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus: Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340:493–501.
17.Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002;39:549–555.
18.Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and Chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339–343.
19.Conly JM, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis 1989;159:310–319.
20.Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent Polyurethane film as an intravenous catheter dressing: a meta-analysis of the infection risks. JAMA 1992;267:2072–2076.
21.Fitchie C. Central venous catheter-related infection and dressing type. Intensive Critical Care Nursing 1992;8:199–202.
22.National Kidney Foundation. Prevention of complications: infection. In: National Kidney Foundation. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. New York: National Kidney Foundation; 2002.